![](/img/cover-not-exists.png)
The histone deacetylase inhibitor SAHA sensitizes acute myeloid leukemia cells to a combination of nucleoside analogs and the DNA-alkylating agent busulfan
Song, Guiyun, Valdez, Benigno C., Li, Yang, Dominguez, Jose R., Corn, Paul, Champlin, Richard E., Andersson, Borje S.Volume:
55
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2013.856007
Date:
July, 2014
File:
PDF, 1.83 MB
english, 2014